MDCX — Medicus Pharma Ltd. Common Stock
$2.51+0.40%
Last close: · regular session
Last 60 sessions
MDCX closed at $2.51 (+0.40%) on Oct 26, 2026. Active shelf registration (S-3, Jan 2026). Float: 53.3M shares. Latest SEC filing: 424B3 on May 28, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for MDCX in the TickerWise workspace.
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: CA
- Exchange: NASDAQ
- Employees: 12
- Website: https://medicuspharma.com
Latest SEC filings for MDCX
Latest MDCX news
- Medicus Pharma restores Nasdaq compliance; stock rises premarket Read article
- Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances Read article
- Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value Read article
- Medicus Pharma files streamlined Phase 2b/3 prostate cancer trial design with FDA Read article
- Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.